Evidence map›Paper›PMID 39888081›Full record

ArticleHistopathology2025

Analysis of benign neoplasms of the rete testis formerly termed "Sertoliform cystadenomas" demonstrates that they are not Sertoli cell tumours with intra-rete growth.

Katrina Collins, Kvetoslava Michalova, Dario de Biase, Costantino Ricci, Giovanni Tallini, Jennifer B Gordetsky, Muhammad T Idrees, Maurizio Colecchia, Thomas M Ulbright, Andres M Acosta

Abstract read
In one paragraph

Article in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Characterizing Paratesticular Neoplasms in Proteus Syndrome.The American journal of surgical pathology · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Katrina CollinsDepartment of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0002-9603-6731
Kvetoslava MichalovaDepartment of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd., Pilsen, Czech Republic.
Dario de BiaseSolid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Costantino RicciPathology Unit, DIAP-Dipartimento InterAziendale di Anatomia Patologica di Bologna, Maggiore Hospital-AUSL Bologna, Bologna, Italy.
Giovanni TalliniSolid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Jennifer B GordetskyDepartment of Pathology Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID https://orcid.org/0000-0002-0745-2160
Muhammad T IdreesDepartment of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Maurizio ColecchiaDepartment of Pathology, Università, Vita Salute San Raffaele, Milan, Italy.
Thomas M UlbrightDepartment of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Andres M AcostaDepartment of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0001-8817-6331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsBenign tumours of the rete testis include mostly cystadenomas and adenomas. A subset with tubular or tubulopapillary architecture shows morphological similarities to Sertoli cell tumours; these neoplasms were previously termed "Sertoliform cystadenomas of the rete testis". In the most recent WHO classification, they have been interpreted as Sertoli cell tumours, not otherwise specified (NOS), with pure intra-rete growth, and therefore excluded as an entity. The remaining cystadenomas of the rete testis vaguely resemble tumours of Mullerian origin arising in the ovaries. In this study we analyse benign tumours of the rete testis, including a subset with Sertoliform features. METHODS AND

resultsBenign neoplasms of the rete testis were identified through query of consultation and institutional files. Clinicopathologic data were collected, and available slides were reviewed. Cases were assessed using IHC and three separate DNA sequencing panels. Eleven tumours from patients 32-78 years old were evaluated. Four were classified as Sertoliform adenomas/cystadenomas, displaying tubulo-papillary or tubular/trabecular architecture; all of them were PAX8-positive and lacked nuclear beta-catenin expression. The remaining seven tumours were benign cystadenomas NOS. Genomic analysis was performed successfully in 10/11 tumours (including all Sertoliform adenomas/cystadenomas) and revealed no pathogenic variants in CTNNB1, KRAS, or BRAF.

conclusionSertoliform cystadenomas of the rete testis differ from Sertoli cell tumours NOS, as evidenced by the absence of molecular markers characteristic of Sertoli cell tumours. The remaining benign cystadenomas lack molecular alterations seen in Mullerian tumors of the ovaries.

Indexed as

CystadenomaRete TestisSertoli Cell TumorTesticular NeoplasmsAdultAgedBiomarkers, TumorHumansMaleMiddle AgedBiomarkers, Tumoradenomatous hyperplasia reteorchiectomyparatestisrete testisSertoliform cystadenomatesticular neoplasm

Identifiers

PMID39888081
PMCPMC12129600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.